Literature DB >> 11298644

Role of EspF in host cell death induced by enteropathogenic Escherichia coli.

J K Crane1, B P McNamara, M S Donnenberg.   

Abstract

Enteropathogenic Escherichia coli (EPEC) causes diarrhoea in children in developing countries. Many EPEC genes involved in virulence are contained within the locus of enterocyte effacement (LEE), a large pathogenicity island. One of the genes at the far righthand end of the LEE encodes EspF, an EPEC secreted protein of unknown function. EspF, like the other Esps, is a substrate for secretion by the type III secretory system. Previous studies found that an espF mutant behaved as wild type in assays of adherence, invasion, actin condensation and tyrosine phosphorylation. As EPEC can kill host cells, we tested esp gene mutants for host cell killing ability. The espF mutant was deficient in host cell killing despite having normal adherence. The addition of purified EspF to tissue culture medium did not cause any damage to host cells, but expression of espF in COS or HeLa cells caused cell death. The mode of cell death in cells transfected with espF appeared to be pure apoptosis. EspF appears to be an effector of host cell death in epithelial cells; its proline-rich structure suggests that it may act by binding to SH3 domains or EVH1 domains of host cell signalling proteins.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11298644     DOI: 10.1046/j.1462-5822.2001.00103.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  50 in total

Review 1.  Pathogenesis and evolution of virulence in enteropathogenic and enterohemorrhagic Escherichia coli.

Authors:  M S Donnenberg; T S Whittam
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Induction of epithelial cell death including apoptosis by enteropathogenic Escherichia coli expressing bundle-forming pili.

Authors:  M Abul-Milh; Y Wu; B Lau; C A Lingwood; D Barnett Foster
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

Review 3.  Virulence of enteropathogenic Escherichia coli, a global pathogen.

Authors:  S C Clarke; R D Haigh; P P E Freestone; P H Williams
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

4.  Comparative proteomic analysis of extracellular proteins of enterohemorrhagic and enteropathogenic Escherichia coli strains and their ihf and ler mutants.

Authors:  M Li; I Rosenshine; S L Tung; X H Wang; D Friedberg; C L Hew; K Y Leung
Journal:  Appl Environ Microbiol       Date:  2004-09       Impact factor: 4.792

5.  Intestinal damage in enterohemorrhagic Escherichia coli infection.

Authors:  Zivile D Békássy; Carla Calderon Toledo; Gustav Leoj; Anncharlotte Kristoffersson; Shana R Leopold; Maria-Thereza Perez; Diana Karpman
Journal:  Pediatr Nephrol       Date:  2010-09-01       Impact factor: 3.714

Review 6.  Interactions between bacterial pathogens and mitochondrial cell death pathways.

Authors:  Thomas Rudel; Oliver Kepp; Vera Kozjak-Pavlovic
Journal:  Nat Rev Microbiol       Date:  2010-09-06       Impact factor: 60.633

7.  The EspF effector, a bacterial pathogen's Swiss army knife.

Authors:  Ashleigh Holmes; Sabrina Mühlen; Andrew J Roe; Paul Dean
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

8.  Interaction of enteropathogenic Escherichia coli with human intestinal mucosa: role of effector proteins in brush border remodeling and formation of attaching and effacing lesions.

Authors:  Robert K Shaw; Jennifer Cleary; Michael S Murphy; Gad Frankel; Stuart Knutton
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

9.  Temporal expression of enteropathogenic Escherichia coli virulence genes in an in vitro model of infection.

Authors:  Laura Q Leverton; James B Kaper
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 10.  Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation.

Authors:  Junkal Garmendia; Gad Frankel; Valérie F Crepin
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.